Skip to main content
Premium Trial:

Request an Annual Quote

Cofactor Genomics Installs SOLiD 4; Sequencing Ozzy Osbourne's Genome

Premium

This article was originally published June 30.

Next-gen sequencing service provider Cofactor Genomics said last week that it has installed an Applied Biosystems SOLiD 4 sequencer and plans to use the instrument to sequence the genome of British heavy metal legend Ozzy Osbourne.

For the project, St. Louis-based Cofactor Genomics will construct and sequence DNA libraries, while direct-to-consumer genome analysis firm Knome will analyze and interpret the data.

According to Sky News, which first reported the project in June, the goal is to determine how Osbourne "is still alive after decades of drug and alcohol abuse."

The project is another example of celebrity genome sequencing: in March, Illumina said that it had sequenced the genome of American actress Glenn Close on its Genome Analyzer platform.

Cofactor Genomics, founded in 2008 by former scientists of the Genome Center at Washington University, focuses exclusively on next-gen sequencing services (IS 12/2/2008) and currently has the Illumina and SOLiD platforms in house.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.